1. Home
  2. VTRS vs TXRH Comparison

VTRS vs TXRH Comparison

Compare VTRS & TXRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTRS
  • TXRH
  • Stock Information
  • Founded
  • VTRS 1961
  • TXRH 1993
  • Country
  • VTRS United States
  • TXRH United States
  • Employees
  • VTRS N/A
  • TXRH N/A
  • Industry
  • VTRS Medicinal Chemicals and Botanical Products
  • TXRH Restaurants
  • Sector
  • VTRS Health Care
  • TXRH Consumer Discretionary
  • Exchange
  • VTRS Nasdaq
  • TXRH Nasdaq
  • Market Cap
  • VTRS 10.6B
  • TXRH 12.6B
  • IPO Year
  • VTRS N/A
  • TXRH 2004
  • Fundamental
  • Price
  • VTRS $9.37
  • TXRH $186.56
  • Analyst Decision
  • VTRS Hold
  • TXRH Buy
  • Analyst Count
  • VTRS 5
  • TXRH 20
  • Target Price
  • VTRS $10.40
  • TXRH $192.05
  • AVG Volume (30 Days)
  • VTRS 9.5M
  • TXRH 802.5K
  • Earning Date
  • VTRS 08-07-2025
  • TXRH 08-07-2025
  • Dividend Yield
  • VTRS 5.13%
  • TXRH 1.48%
  • EPS Growth
  • VTRS N/A
  • TXRH 30.91
  • EPS
  • VTRS N/A
  • TXRH 6.48
  • Revenue
  • VTRS $14,330,200,000.00
  • TXRH $5,499,763,000.00
  • Revenue This Year
  • VTRS N/A
  • TXRH $11.22
  • Revenue Next Year
  • VTRS $1.85
  • TXRH $8.90
  • P/E Ratio
  • VTRS N/A
  • TXRH $28.79
  • Revenue Growth
  • VTRS N/A
  • TXRH 15.09
  • 52 Week Low
  • VTRS $6.85
  • TXRH $148.73
  • 52 Week High
  • VTRS $13.55
  • TXRH $206.04
  • Technical
  • Relative Strength Index (RSI)
  • VTRS 58.40
  • TXRH 50.01
  • Support Level
  • VTRS $8.84
  • TXRH $181.32
  • Resistance Level
  • VTRS $9.29
  • TXRH $190.77
  • Average True Range (ATR)
  • VTRS 0.22
  • TXRH 3.19
  • MACD
  • VTRS -0.01
  • TXRH -0.26
  • Stochastic Oscillator
  • VTRS 88.33
  • TXRH 49.14

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About TXRH Texas Roadhouse Inc.

Texas Roadhouse Inc is a restaurant company operating predominantly in the casual dining segment. The company manages its restaurant and franchising operations by concept and, as a result, has identified Texas Roadhouse, Bubba's 33, Jaggers, and retail initiatives as separate operating segments. In addition, it has identified Texas Roadhouse and Bubba's 33 as reportable segments. Maximum revenue for the company is generated from the Texas Roadhouse segment, which is a moderately priced, full-service, casual dining restaurant concept offering steaks, a selection of ribs, seafood, chicken, pork chops, pulled pork, vegetable plates, and an assortment of hamburgers, salads, and sandwiches.

Share on Social Networks: